Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DMetrix was a pioneering medical technology company that specialized in the development of ultra-fast digital pathology systems. Founded as a spin-off from the University of Arizona, the company introduced the first whole-slide imaging scanners powered by proprietary array microscopy technology. This innovation allowed for the simultaneous capture of multiple image tiles, drastically reducing the time required to digitize glass pathology slides compared to conventional methods. Their flagship products, including the DX-40 and DX-80, were designed to improve diagnostic efficiency and enable remote consultation for pathologists. In 2011, DMetrix was acquired by Leica Biosystems, a division of Danaher Corporation, to integrate its high-speed scanning capabilities into Leica's digital pathology suite.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DMetrix.